Did not become law. It stopped in the House of Representatives's Professional Licensure Committee on February 3, 2017. The 2017–2018 session has ended.
2017–2018 Regular Session
House Bill 124
An Act amending the act of December 20, 1985 (P.L.457, No.112), known as the Medical Practice Act of 1985, providing for provision of buprenorphine and legend drugs and further providing for reasons for refusal, revocation, suspension or other corrective actions against a licensee or certificate holder.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
22 co-sponsors
HARRY A. READSHAW III, Mindy Fee, Michael J. Driscoll, JOHN J. TAYLOR, THOMAS P. MURT, DAVID R. MILLARD, Jack Rader Jr., Brett R. Miller, TINA PICKETT, TINA M. DAVIS, GERALD J. MULLERY, McNEILL, KATHARINE M. WATSON, KAREN BOBACK, Dan L. Miller, JUSTIN J. SIMMONS, STANLEY E. SAYLOR, BRYAN D. CUTLER, Bud Cook, Judy Ward, Mark Rozzi, JOHN T. GALLOWAY
Its course
February 3 to February 3, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesFeb 3 to Feb 3 · stopped0 days
Professional LicensureFeb 3 to Feb 3 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Feb 3
- Feb 3Sent to PROFESSIONAL LICENSURE
All 1 actions, as published
- Feb 3Referred to PROFESSIONAL LICENSURE, Feb. 3, 2017 [House]House of Representatives